Alimera Sciences Signs Agreement for Exclusive Distributor of ILUVIEN® in Spain
Mar 13, 2017 11:30 am UTC| Business
Brill Pharma S.L. to also serve as agent in price negotiations with the Spanish Ministry of Health ATLANTA, March 13, 2017 -- Alimera Sciences, Inc. (NASDAQ:ALIM) (Alimera), a pharmaceutical company that specializes...
Applied Materials Honored as a 2017 World’s Most Ethical Company
Mar 13, 2017 11:30 am UTC| Business
Recognized by the Ethisphere Institute for six consecutive years for leading with integrity and ethical business practicesSANTA CLARA, Calif., March 13, 2017 -- Applied Materials, Inc. announced today that it has been...
Marinus Pharmaceuticals Provides Business Update and 2016 Financial Results
Mar 13, 2017 11:30 am UTC| Business
RADNOR, Pa., March 13, 2017 -- Marinus Pharmaceuticals, Inc. (Nasdaq:MRNS), a biopharmaceutical company dedicated to the development of innovative therapeutics to treat epilepsy and neuropsychiatric disorders, today...
Bellerophon Reports Fourth Quarter 2016 Financial Results and Provides Business Update
Mar 13, 2017 11:30 am UTC| Business
WARREN, N.J., March 13, 2017 -- Bellerophon Therapeutics,Inc. (Nasdaq:BLPH), a clinical-stage biotherapeutics company, today provided a business update and reported financial results for the fourth quarter and full year...
Mar 13, 2017 11:30 am UTC| Business
DEVON, Pa., March 13, 2017 -- Zynerba Pharmaceuticals, Inc. (NASDAQ:ZYNE), a clinical-stage specialty pharmaceutical company dedicated to the development of innovative transdermal synthetic cannabinoid treatments, today...
Mar 13, 2017 11:30 am UTC| Business
WALTHAM, Mass., March 13, 2017 -- EyeGate Pharmaceuticals, Inc. (NASDAQ:EYEG) (“EyeGate” or the “Company”), a clinical-stage specialty pharmaceutical company that focuses on developing and commercializing products for...
TG Therapeutics, Inc. to Present at the 29th Annual ROTH Conference
Mar 13, 2017 11:30 am UTC| Business
NEW YORK, March 13, 2017 -- TG Therapeutics, Inc. (Nasdaq:TGTX) today announced that Michael S. Weiss, the Company’s Executive Chairman and Chief Executive Officer, will present at the 29th Annual ROTH Conference, being...